PICI Network Researchers to Present at SITC Spring Scientific

Investigators from the Parker Institute for Cancer Immunotherapy (PICI) Network will discuss factors that affect the host and response to immunotherapy beyond the tumor microenvironment, at the Society for Immunotherapy of Cancer (SITC) Spring Scientific, March 15-17 in Denver and online.

The conference, titled “Host Immunity in Immunotherapy Responses: From Discoveries to Precision Oncology,” will include discussions of scientific breakthroughs, cutting-edge methodologies and technologies, and clinical studies pertaining to environmental, genetic and patient-specific factors that affect patient health and response to immunotherapy.

Session co-chairs and presenters include these PICI Network members: 

• John Wherry, PhD, (Twitter: @EJohnWherry) co-center director of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania and chair of the Department of Systems Pharmacology & Translational Therapeutics at Penn
  
• Matthew H. Spitzer, PhD, (Twitter: @SpitzerLab), an associate professor of otolaryngology at the University of California, San Francisco and an affiliate investigator at Gladstone Institutes
• Avery D. Posey, PhD, (Twitter: @IAmDrDex) an instructor in the Department of Pathology and Laboratory Medicine at Penn

Kenneth Hu, PhD, (Twitter: @KenHu77) a postdoctoral scholar and Parker Bridge Fellow (in partnership with the V Foundation for Cancer Research) at University of California San Francisco, also will present.

Additional details are below. All times are Mountain Daylight Time. Please note that all events listed are subject to change. For the most current information, visit the conference program. 

Wednesday, March 15 

Session: Workshop: Integrating Spatial-Omics in IO/Single Cell Analysis
Presenter: Kenneth Hu, PhD
Presentation: Image Analysis of Immune Contexture
Time: 3:40 p.m. 

Thursday, March 16 

Session: Session V: Immune-Related Toxicity and COVID
Co-Chair and Presenter: E. John Wherry, PhD
Time: 9:35-10:50 a.m. 

Presentation: Use of ‘Analytical Vaccination’ to Predict Immune Related Adverse Events to Checkpoint Blockade
Time: 10:15 a.m.  

Session: Session VI: Novel Insights into Adoptive Cell Therapy
Co-Chair and Presenter: Avery D. Posey, PhD
Time: 11:05 a.m.-12:20 p.m. 

Presentation: Tumor Mechanisms of Resistance to CAR T Cells
Time: 11:07 a.m. 

Friday, March 17

Session: Session VIII: Insights from Non-Tumor Sites in IO Response
Co-Chair and Presenter: Matthew H. Spitzer, PhD
Time: 9:35-10:50 a.m. 

Presentation: CD8 T Cell Responses to Cancer Immunotherapy in Human Lymph Nodes
Time: 9:35 a.m.